Breaking News Instant updates and real-time market news.

$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

 14:17
10/12/20
 10/12
14:17
 10/12/20
14:17

NASDAQ market internals summary

Volume is above average for this time of day. Breadth is bullish across the board. Advancing Issues: 1975 / Declining Issues: 1420 -- for a ratio of 1.4 to 1. Advancing Volume: 1,728,989,000 / Declining Volume: 724,396,000 -- for a ratio of 2.4 to 1. New 52-Week Highs: 244 / New 52-Week Lows: 22.

TODAY'S FREE FLY STORIES

Earnings
Broadcom sees Q2 revenue approximately $6.5B, consensus $6.33B » 16:16
03/04/21
03/04
16:16
03/04/21
16:16
AVGO

Broadcom

$443.23 /

-19.235 (-4.16%)

Sees Q2 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

02/22/21
ForeScout appoints Kevin O'Leary chief product officer
12/21/20
Broadcom CEO sells over 14,000 common shares
12/16/20
Synnex awarded commercial aggregator agreement with Broadcom
12/10/20
Broadcom CEO says 'we concluded the year with strong fourth quarter results'
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

03/02/21 Credit Suisse
Broadcom price target raised to $580 from $480 at Credit Suisse
03/01/21 JPMorgan
Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

16:15 Today
Broadcom reports Q1 adjusted EPS $6.61, consensus $6.55
13:23 Today
Notable companies reporting after market close
12/10/20
Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B
12/10/20
Broadcom reports Q4 adjusted EPS $6.35, consensus $6.25
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

01/12/21
On, Lumentum seen among top semiconductors takeout candidates for 2021
12/28/20
Kinnate initiations, Nikola target change among today's top calls on Wall Street
12/11/20
Fly Intel: Wall Street's top stories for Friday
12/11/20
Fly Intel: Wall Street's top stories at midday
17:00 Today
Broadcom - AVGO
04/05/21
Broadcom Inc.
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

11/03/20
Unusually active option classes on open November 3rd
Earnings
Gap reports Q4 EPS 61c, consensus 18c » 16:16
03/04/21
03/04
16:16
03/04/21
16:16
GPS

Gap

$25.43 /

-0.31 (-1.20%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPS Gap
$25.43 /

-0.31 (-1.20%)

02/24/21
Gap to open distribution center in Longview, Texas
01/21/21
Gap's Athleta adds extended sizing to 350 styles in its 200 stores, online
11/25/20
Gap falls -19.4%
11/25/20
Gap falls -16.9%
GPS Gap
$25.43 /

-0.31 (-1.20%)

02/16/21 Jefferies
Gap assumed with a Hold at Jefferies
01/21/21 Deutsche Bank
Gap price target raised to $26 from $25 at Deutsche Bank
01/15/21 B. Riley Securities
Gap price target lowered to $22 from $31 at B. Riley Securities
11/25/20
Fly Intel: Top five analyst downgrades
GPS Gap
$25.43 /

-0.31 (-1.20%)

13:23 Today
Notable companies reporting after market close
11/24/20
Gap reports Q3 Old Navy SSS up 17% y/y
11/24/20
Gap sees Q4 net sales equal or slightly higher than last year, consensus $4.54B
11/24/20
Gap reports Q3 EPS 25c, consensus 32c
GPS Gap
$25.43 /

-0.31 (-1.20%)

02/28/21
Macy's, Gap letting customers buy now, pay later, WSJ reports
12/02/20
UPS imposes shipping restrictions on Gap, Nike, WSJ reports
10/20/20
Gap reviewing options for its Gap Europe business, Bloomberg says
10/20/20
Gap reviewing options for its Gap Europe business, Bloomberg says
GPS Gap
$25.43 /

-0.31 (-1.20%)

02/16/21
American Express downgrade among today's top calls on Wall Street
11/25/20
Fly Intel: Wall Street's top stories for Wednesday
11/25/20
Fly Intel: Wall Street's top stories at midday
11/25/20
Ford, Gap downgrades among today's top calls on Wall Street
17:00 Today
Gap - GPS
GPS Gap
$25.43 /

-0.31 (-1.20%)

02/02/21
Gap call volume above normal and directionally bullish
11/27/20
Notable open interest changes for November 27th
11/24/20
Gap options imply 9.2% move in share price post-earnings
11/23/20
Early notable gainers among liquid option names on November 23rd
Earnings
Playa Hotels & Resorts reports Q4 EPS (55c), consensus (45c) » 16:16
03/04/21
03/04
16:16
03/04/21
16:16
PLYA

Playa Hotels & Resorts

$6.90 /

-0.105 (-1.50%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

01/21/21
Davidson Kempner reports 8.46% passive stake in Playa Hotels & Resorts
11/16/20
Hilton La Romana reopens following temporary closure
11/04/20
Playa Hotels & Resorts to sell the Dreams Puerto Aventuras for $34.5M
10/08/20
Playa Hotels & Resorts resumes normal operations at Yucatan resorts
PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

01/11/21 Macquarie
Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie
12/15/20 Citi
Playa Hotels & Resorts upgraded to Neutral from Sell at Citi
07/02/20 Citi
Playa Hotels & Resorts price target raised to $3 from $1 at Citi
04/29/20 SunTrust
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

11/04/20
Playa Hotels & Resorts reports Q3 EPS (57c), consensus (45c)
  • 07
    Jan
  • 19
    Nov
PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

01/06/21
Fly Intel: After-Hours Movers
03/05/21
Playa Hotels & Resorts - PLYA
Earnings
NuCana reports Q4 net loss GBP 12.3M versus GBP a loss of GBP 7M last year » 16:16
03/04/21
03/04
16:16
03/04/21
16:16
NCNA

NuCana

$4.66 /

-0.45 (-8.81%)

As of December 31, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCNA NuCana
$4.66 /

-0.45 (-8.81%)

01/15/21
NuCana presents interim data form NuTide:302 study of NUC-3373
01/13/21
NuCana PLC (ADS) trading resumes
01/13/21
NuCana PLC (ADS) trading halted, volatility trading pause
11/30/20
NuCana announces final results from Acelarin plus cisplatin study published
NCNA NuCana
$4.66 /

-0.45 (-8.81%)

01/15/21 Piper Sandler
Piper sees more evidence that NuCana's NUC-3373 'a better 5-FU'
12/01/20 H.C. Wainwright
NuCana price target lowered to $10 from $15 at H.C. Wainwright
11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
NCNA NuCana
$4.66 /

-0.45 (-8.81%)

11/19/20
NuCana reports Q3 EPS GBP( 0.24) versus GBP (0.12) in Q319
  • 17
    Sep
NCNA NuCana
$4.66 /

-0.45 (-8.81%)

11/30/20
Fly Intel: After-Hours Movers
11/19/20
Fly Intel: After-Hours Movers
09/17/20
Fly Intel: Pre-market Movers
09/16/20
Fly Intel: After-Hours Movers
03/02/21
41st Annual Healthcare Virtual Conference
03/23/21
NuCana
Earnings
Manchester United reports Q2 adjusted EPS GBp21.69 vs. GBp15.67 last year » 16:16
03/04/21
03/04
16:16
03/04/21
16:16
MANU

Manchester United

$18.72 /

-0.84 (-4.29%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MANU Manchester United
$18.72 /

-0.84 (-4.29%)

11/20/20
Manchester United confirms club experienced cyberattack on its systems
MANU Manchester United
$18.72 /

-0.84 (-4.29%)

11/12/20
Manchester United reports Q1 adjusted EPS (GBP15.12) vs. GBP2.35 last year
16:30 Today
Manchester United - MANU
Technical Analysis
NYSE market internals summary » 16:16
03/04/21
03/04
16:16
03/04/21
16:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume was above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

15:16 Today
NYSE market internals summary
14:16 Today
NYSE market internals summary
13:16 Today
NYSE market internals summary
12:16 Today
NYSE market internals summary
Earnings
Fulgent Genetics sees FY21 EPS $12.50, consensus $11.55 » 16:15
03/04/21
03/04
16:15
03/04/21
16:15
FLGT

Fulgent Genetics

$85.08 /

-7.3 (-7.90%)

Sees FY21 revenue $800M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

02/16/21
Fulgent Genetics, BioIQ partner on COVID-19 testing programs
12/29/20
Fulgent Genetics extends partnership with NTC DOE and Health
12/17/20
PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program
11/18/20
Fulgent Genetics, LANES, LA DHS partner on COVID-19 testing
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

02/03/21 Piper Sandler
Fulgent Genetics price target raised to $135 from $100 at Piper Sandler
02/01/21 Oppenheimer
Fulgent Genetics price target raised to $130 from $75 at Oppenheimer
02/01/21 Oppenheimer
Invitae downgraded to Perform on valuation at Oppenheimer
01/08/21 Credit Suisse
Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

16:13 Today
Fulgent Genetics reports Q4 EPS $6.20, consensus $4.05
11/23/20
Fulgent Genetics raises 2020 revenue view to at least $300M from $235M
11/09/20
Fulgent Genetics reports Q3 EPS$2.08 , consensus 55c
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

09/09/20
Report says U.S. may need 193M coronavirus tests per month, STAT reports
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

01/08/21
Fly Intel: Wall Street's top stories for Friday
01/08/21
Fly Intel: Wall Street's top stories at midday
11/09/20
Pfizer, BioNTech lift market as COVID vaccine shows effectiveness
09/22/20
Fly Intel: Wall Street's top stories for Tuesday
03/16/21
31st Annual Healthcare Virtual Conference
16:30 Today
Fulgent Genetics - FLGT
Earnings
Broadcom reports Q1 adjusted EPS $6.61, consensus $6.55 » 16:15
03/04/21
03/04
16:15
03/04/21
16:15
AVGO

Broadcom

$443.23 /

-19.235 (-4.16%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

02/22/21
ForeScout appoints Kevin O'Leary chief product officer
12/21/20
Broadcom CEO sells over 14,000 common shares
12/16/20
Synnex awarded commercial aggregator agreement with Broadcom
12/10/20
Broadcom CEO says 'we concluded the year with strong fourth quarter results'
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

03/02/21 Credit Suisse
Broadcom price target raised to $580 from $480 at Credit Suisse
03/01/21 JPMorgan
Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

13:23 Today
Notable companies reporting after market close
12/10/20
Broadcom sees Q1 revenue approximately $6.6B, consensus $6.52B
12/10/20
Broadcom reports Q4 adjusted EPS $6.35, consensus $6.25
12/10/20
Notable companies reporting after market close
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

01/12/21
On, Lumentum seen among top semiconductors takeout candidates for 2021
12/28/20
Kinnate initiations, Nikola target change among today's top calls on Wall Street
12/11/20
Fly Intel: Wall Street's top stories for Friday
12/11/20
Fly Intel: Wall Street's top stories at midday
17:00 Today
Broadcom - AVGO
04/05/21
Broadcom Inc.
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

11/03/20
Unusually active option classes on open November 3rd
General news
Week of 3/3 Fed Balance Sheet to be released at 16:30  16:15
03/04/21
03/04
16:15
03/04/21
16:15
 
Earnings
Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) » 16:13
03/04/21
03/04
16:13
03/04/21
16:13
RPTX

Repare Therapeutics

$27.36 /

-4.31 (-13.61%)

, BMY

Bristol-Myers

$59.25 /

-1.5 (-2.47%)

Cash and cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$59.25 /

-1.5 (-2.47%)

02/26/21
Bristol-Myers receives positive CHMP opinion for Opdivo/Cabometyx combination
02/24/21
Bluebird Bio, Bristol-Myers' KarMMa study meets primary endpoint, NEJM reports
02/24/21
Prothena announces presentation of new preclinical PRX005 data
02/22/21
Compugen expands clinical collaboration agreement with Bristol-Myers
RPTX Repare Therapeutics
$27.36 /

-4.31 (-13.61%)

03/01/21 Berenberg
Repare Therapeutics initiated with a Buy at Berenberg
12/29/20 Northland
Northland ups Repare Therapeutics price target to $42, calls a Top Pick for 2021
10/28/20
Fly Intel: Top five analyst initiations
10/28/20 Northland
Repare Therapeutics initiated with an Outperform at Northland
BMY Bristol-Myers
$59.25 /

-1.5 (-2.47%)

02/12/21 Morgan Stanley
Amgen court decision may have readthrough for Gilead, says Morgan Stanley
02/02/21 BTIG
Prothena upgraded to Buy at BTIG on birtamimab 'revival'
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
RPTX Repare Therapeutics
$27.36 /

-4.31 (-13.61%)

11/11/20
Repare Therapeutics reports Q3 EPS (37c), consensus (38c)
BMY Bristol-Myers
$59.25 /

-1.5 (-2.47%)

02/24/21
CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M
02/04/21
Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45
02/04/21
Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41
02/03/21
Notable companies reporting before tomorrow's open
  • 19
    Jun
BMY Bristol-Myers
$59.25 /

-1.5 (-2.47%)

02/15/21
Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports
12/23/20
Judge rules against White House drug pricing rule, Reuters says
11/23/20
EU seeks easier access to generic medicines, Reuters says
11/20/20
Trump to release new rules aimed at lowering drug prices, WSJ reports
BMY Bristol-Myers
$59.25 /

-1.5 (-2.47%)

02/09/21
Fly Intel: Pre-market Movers
12/26/20
Week in review: How Trump's policies moved stocks
11/21/20
Week in review: How Trump's policies moved stocks
11/05/20
Fly Intel: Pre-market Movers
03/16/21
Healthcare Corporate Access Virtual Day
03/16/21
Healthcare Corporate Access Virtual Day
03/27/21
PDUFA Date for Ide-Cel
05/20/21
PDUFA Date for CM-577 - Opdivo
05/25/21
PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo
05/30/21
PDUFA Date for Zeposia (Ozanimod)
BMY Bristol-Myers
$59.25 /

-1.5 (-2.47%)

01/20/21
Unusually active option classes on open January 20th
01/11/21
Unusually active option classes on open January 11th
01/05/21
Bristol Myers Squibb call volume above normal and directionally bullish
01/04/21
Bristol Myers Squibb call buyer realizes 25% same-day gains
Earnings
Fulgent Genetics reports Q4 EPS $6.20, consensus $4.05 » 16:13
03/04/21
03/04
16:13
03/04/21
16:13
FLGT

Fulgent Genetics

$85.08 /

-7.3 (-7.90%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

02/16/21
Fulgent Genetics, BioIQ partner on COVID-19 testing programs
12/29/20
Fulgent Genetics extends partnership with NTC DOE and Health
12/17/20
PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program
11/18/20
Fulgent Genetics, LANES, LA DHS partner on COVID-19 testing
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

02/03/21 Piper Sandler
Fulgent Genetics price target raised to $135 from $100 at Piper Sandler
02/01/21 Oppenheimer
Fulgent Genetics price target raised to $130 from $75 at Oppenheimer
02/01/21 Oppenheimer
Invitae downgraded to Perform on valuation at Oppenheimer
01/08/21 Credit Suisse
Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

11/23/20
Fulgent Genetics raises 2020 revenue view to at least $300M from $235M
11/09/20
Fulgent Genetics reports Q3 EPS$2.08 , consensus 55c
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

09/09/20
Report says U.S. may need 193M coronavirus tests per month, STAT reports
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

01/08/21
Fly Intel: Wall Street's top stories for Friday
01/08/21
Fly Intel: Wall Street's top stories at midday
11/09/20
Pfizer, BioNTech lift market as COVID vaccine shows effectiveness
09/22/20
Fly Intel: Wall Street's top stories for Tuesday
03/16/21
31st Annual Healthcare Virtual Conference
16:30 Today
Fulgent Genetics - FLGT
Earnings
Comscore reports Q4 EPS (18c), consensus (15c) » 16:13
03/04/21
03/04
16:13
03/04/21
16:13
SCOR

Comscore

$3.22 /

-0.27 (-7.74%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCOR Comscore
$3.22 /

-0.27 (-7.74%)

03/01/21
Comscore, Omnicom announce expanded data agreement
02/23/21
Comscore receives patent from USPTO for ad effectiveness
02/16/21
Starboard Value buys ON Semi, cuts Advance Auto stake in Q4
02/16/21
Comscore signs new agreement with SHINEZ.io for digital audience measurement
SCOR Comscore
$3.22 /

-0.27 (-7.74%)

01/11/21 Loop Capital
Comscore upgraded to Buy from Hold at Loop Capital
01/11/21 Loop Capital
Comscore upgraded to Buy from Hold at Loop Capital
08/19/20 Truist
Comscore most likely to remain independent, says Truist
SCOR Comscore
$3.22 /

-0.27 (-7.74%)

11/09/20
Comscore reports Q3 EPS (16c), consensus (19c)
SCOR Comscore
$3.22 /

-0.27 (-7.74%)

01/07/21
Comscore near financing deal with Charter, Qurate and Cerberus, WSJ says
01/07/21
Comscore near financing deal with Charter, Qurate and Cerberus, WSJ says
SCOR Comscore
$3.22 /

-0.27 (-7.74%)

11/09/20
Fly Intel: After-Hours Movers
03/11/21
2021 Consumer, Industrials, & TMT Investor Virtual Conference
03/09/21
comScore Inc.
Earnings
Grid Dynamics sees FY21 revenue of at least $156M, consensus $132.3M » 16:13
03/04/21
03/04
16:13
03/04/21
16:13
GDYN

Grid Dynamics

$14.81 /

-0.85 (-5.43%)

For the full year 2021,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/14/20
Grid Dynamics acquires Daxx, terms undisclosed
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/16/20 Canaccord
Grid Dynamics price target raised to $15 from $11 at Canaccord
10/15/20 Cowen
Grid Dynamics initiated with an Outperform at Cowen
09/28/20 Canaccord
Grid Dynamics initiated with a Buy at Canaccord
06/25/20 Loop Capital
Grid Dynamics price target raised to $84 from $77 at Loop Capital
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

16:12 Today
Grid Dynamics sees Q1 revenue $35.0M-$36.5M, consensus $28.56M
16:10 Today
Grid Dynamics reports Q4 adjusted EPS 4c, consensus 3c
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/21/20
Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

11/30/20
Two new option listings and one option delisting on November 30th
Hot Stocks
Durect in discussions with potential partners for Posimir » 16:12
03/04/21
03/04
16:12
03/04/21
16:12
DRRX

Durect

$2.04 /

-0.145 (-6.65%)

The company said it is in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.04 /

-0.145 (-6.65%)

16:10 Today
Durect discontinues Covid trial due to lack of patients, other treatments
02/02/21
Durect announces FDA approval of POSIMIR
02/02/21
Durect jumps over 40% after FDA posts approval of pain drug
02/02/21
FDA posts approval of Durect pain treatment Posimir
DRRX Durect
$2.04 /

-0.145 (-6.65%)

02/03/21 Jefferies
Posimir should not be significant threat to Pacira's Exparel, says Jefferies
02/03/21 Chardan
Chardan boosts Durect target to $8 with 'final overhang' removed
02/02/21 Oppenheimer
Posimir approval a 'significant positive' for Durect, says Oppenheimer
02/02/21 Roth Capital
Roth reiterates $7 target on Durect after 'surprise' FDA approval
DRRX Durect
$2.04 /

-0.145 (-6.65%)

16:10 Today
Durect reports Q4 cont ops EPS (4c), consensus (3c)
11/02/20
Durect reports Q3 EPS (5c), consensus (4c)
  • 04
    Feb
DRRX Durect
$2.04 /

-0.145 (-6.65%)

11/03/20
Fly Intel: Pre-market Movers
11/02/20
Fly Intel: After-Hours Movers
03/16/21
31st Annual Healthcare Virtual Conference
16:30 Today
Durect - DRRX
Earnings
Imax reports Q4 adjusted EPS (21c), consensus (20c) » 16:12
03/04/21
03/04
16:12
03/04/21
16:12
IMAX

Imax

$20.64 /

-1.12 (-5.15%)

Reports Q4 revenue $56M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMAX Imax
$20.64 /

-1.12 (-5.15%)

02/22/21
Movie theater operators jump as Gov. Cuomo gives greenlight to NYC reopening
02/10/21
iQIYI Launches Imax Enhanced in China
12/22/20
Sony Pictures CEO says 'don't think' will move to 'day and date' film releases
12/17/20
Imax, JinYi Media announce new 12-theatre agreement
IMAX Imax
$20.64 /

-1.12 (-5.15%)

03/01/21 Wedbush
Imax price target raised to $22 from $14 at Wedbush
02/16/21 B. Riley Securities
IMAX format positioned to gain post-pandemic share, says B. Riley Securities
02/16/21 Macquarie
Imax remains best way to play theatrical space, says Macquarie
02/15/21 Benchmark
Benchmark boosts Imax target to $22, says movie goers will return
IMAX Imax
$20.64 /

-1.12 (-5.15%)

10/29/20
Imax reports Q3 EPS (75c), consensus (30c)
IMAX Imax
$20.64 /

-1.12 (-5.15%)

02/22/21
Movie theaters might get OK to reopen in New York City, Deadline says
10/18/20
NY state moves to reopen movie theaters, ski resorts, Bloomberg reports
10/08/20
Imax furloughs 150 employees in U.S., Variety reports
IMAX Imax
$20.64 /

-1.12 (-5.15%)

12/28/20
AMC, Cinemark rise as WW84 scores highest box office opening of pandemic
12/03/20
Fly Intel: Wall Street's top stories for Thursday
11/24/20
Fly Intel: Wall Street's top stories for Tuesday
16:30 Today
Imax - IMAX
IMAX Imax
$20.64 /

-1.12 (-5.15%)

01/05/21
Largest borrow rate increases among liquid names
11/10/20
IMAX call buyer realizes 525% same-day gains
10/23/20
Largest borrow rate increases among liquid names
09/23/20
Unusual call flow in option market yesterday
Earnings
Certara sees FY21 adjusted EPS 20c-24c, consensus 24c » 16:12
03/04/21
03/04
16:12
03/04/21
16:12
CERT

Certara

$30.42 /

-3.55 (-10.45%)

Sees FY21 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CERT Certara
$30.42 /

-3.55 (-10.45%)

03/02/21 Barclays
Certara initiated with an Overweight at Barclays
03/02/21 Barclays
Certara initiated with an Overweight at Barclays
01/05/21 Morgan Stanley
Morgan Stanley starts Certara at Equal Weight, says fully valued
01/05/21 Morgan Stanley
Certara initiated with an Equal Weight at Morgan Stanley
CERT Certara
$30.42 /

-3.55 (-10.45%)

16:11 Today
Certara reports preliminary Q4 adjusted EPS 9c, consensus 3c
  • 11
    Dec
CERT Certara
$30.42 /

-3.55 (-10.45%)

12/13/20
Opening Day: Airbnb shares double in IPO, DoorDash soars in debut
17:00 Today
Certara - CERT
CERT Certara
$30.42 /

-3.55 (-10.45%)

01/28/21
new option listings on January 28th
Earnings
SmileDirectClub sees Q1 revenue up 5-7%, consensus $194.2M » 16:12
03/04/21
03/04
16:12
03/04/21
16:12
SDC

SmileDirectClub

$10.66 /

-0.255 (-2.34%)

"In Q1, we expect…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SDC SmileDirectClub
$10.66 /

-0.255 (-2.34%)

02/25/21
SmileDirectClub to bring telehealth solution to the Netherlands
02/24/21
SmileDirectClub partners with National Dental
02/23/21
SmileDirectClub launches new Pro Whitening System
02/17/21
SmileDirectClub announces Walgreens as retail partner
SDC SmileDirectClub
$10.66 /

-0.255 (-2.34%)

12/08/20 Wolfe Research
SmileDirectClub upgraded to Outperform from Peer Perform at Wolfe Research
11/24/20 JPMorgan
JPMorgan reiterates Overweight on SmileDirectClub after management meetings
09/17/20 Stifel
SmileDirectClub price target raised to $14 from $11 at Stifel
09/09/20 Wolfe Research
Wolfe Research upgrades SmileDirectClub to Peer Perform as shifts pay off
SDC SmileDirectClub
$10.66 /

-0.255 (-2.34%)

16:09 Today
SmileDirectClub reports Q4 (9c) EPS , consensus (10c)
13:23 Today
Notable companies reporting after market close
11/16/20
SmileDirectClub reports Q3 EPS (11c), consensus (14c)
11/16/20
Notable companies reporting after market close
  • 24
    Nov
  • 19
    Nov
SDC SmileDirectClub
$10.66 /

-0.255 (-2.34%)

12/09/20
SmileDirectClub restarts legal dispute with Candid Care, Bloomberg reports
SDC SmileDirectClub
$10.66 /

-0.255 (-2.34%)

10:40 Today
Fly Intel: What to watch in SmileDirectClub's earnings report
12/08/20
Fly Intel: After-Hours Movers
12/08/20
Lowe's upgrade, Coca-Cola initiation among today's top calls on Wall Street
11/24/20
Fly Intel: Wall Street's top stories for Tuesday
03/11/21
2021 Consumer, Industrials, & TMT Investor Virtual Conference
16:30 Today
SmileDirectClub - SDC
SDC SmileDirectClub
$10.66 /

-0.255 (-2.34%)

12:45 Today
SmileDirectClub call volume above normal and directionally bullish
01/28/21
SmileDirectClub call volume above normal and directionally bullish
01/26/21
Unusually active option classes on open January 26th
01/25/21
SmileDirectClub call volume above normal and directionally bullish
Earnings
Grid Dynamics sees Q1 revenue $35.0M-$36.5M, consensus $28.56M » 16:12
03/04/21
03/04
16:12
03/04/21
16:12
GDYN

Grid Dynamics

$14.81 /

-0.85 (-5.43%)

The company expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/14/20
Grid Dynamics acquires Daxx, terms undisclosed
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/16/20 Canaccord
Grid Dynamics price target raised to $15 from $11 at Canaccord
10/15/20 Cowen
Grid Dynamics initiated with an Outperform at Cowen
09/28/20 Canaccord
Grid Dynamics initiated with a Buy at Canaccord
06/25/20 Loop Capital
Grid Dynamics price target raised to $84 from $77 at Loop Capital
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

16:10 Today
Grid Dynamics reports Q4 adjusted EPS 4c, consensus 3c
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/21/20
Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

11/30/20
Two new option listings and one option delisting on November 30th
Earnings
Certara reports preliminary Q4 adjusted EPS 9c, consensus 3c » 16:11
03/04/21
03/04
16:11
03/04/21
16:11
CERT

Certara

$30.42 /

-3.55 (-10.45%)

Reports preliminary Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CERT Certara
$30.42 /

-3.55 (-10.45%)

03/02/21 Barclays
Certara initiated with an Overweight at Barclays
03/02/21 Barclays
Certara initiated with an Overweight at Barclays
01/05/21 Morgan Stanley
Morgan Stanley starts Certara at Equal Weight, says fully valued
01/05/21 Morgan Stanley
Certara initiated with an Equal Weight at Morgan Stanley
  • 11
    Dec
CERT Certara
$30.42 /

-3.55 (-10.45%)

12/13/20
Opening Day: Airbnb shares double in IPO, DoorDash soars in debut
17:00 Today
Certara - CERT
CERT Certara
$30.42 /

-3.55 (-10.45%)

01/28/21
new option listings on January 28th
Syndicate
Ameresco files automatic mixed securities shelf  16:11
03/04/21
03/04
16:11
03/04/21
16:11
AMRC

Ameresco

$48.12 /

-4.905 (-9.25%)

 
ShowHide Related Items >><<
AMRC Ameresco
$48.12 /

-4.905 (-9.25%)

02/17/21
Ameresco in ESA pact with Nyack Public School District for phase ll renovations
02/05/21
Ameresco partners with Navy for $173M energy project at Norfolk Naval Shipyard
02/02/21
Ameresco, Wells Fargo announce collaboration to develop solar generation assets
11/25/20
Ameresco CEO sells 46.3K shares of common stock
AMRC Ameresco
$48.12 /

-4.905 (-9.25%)

03/03/21 Canaccord
Ameresco price target raised to $82 from $52 at Canaccord
03/02/21 Oppenheimer
Ameresco price target raised to $66 from $48 at Oppenheimer
02/09/21 B. Riley Securities
Ameresco price target raised to $72 from $50 at B. Riley Securities
01/26/21 Craig-Hallum
Ameresco price target raised to $75 from $50 at Craig-Hallum
AMRC Ameresco
$48.12 /

-4.905 (-9.25%)

03/01/21
Ameresco sees FY21 EPS $1.18-$1.26, consensus $1.22
03/01/21
Ameresco reports Q4 EPS 47c, consensus 29c
11/02/20
Ameresco raises FY20 adj. EPS view to 94c-$1.00 from 86c-96c
11/02/20
Ameresco reports Q3 adjusted EPS 38c, consensus 25c
AMRC Ameresco
$48.12 /

-4.905 (-9.25%)

03/01/21
Fly Intel: After-Hours Movers
03/09/21
Sustainable Energy & Technology Virtual Conference
03/15/21
33rd Annual Roth Virtual Conference
Earnings
Turtle Beach sees Q1 adjusted EPS 45c, consensus 1c » 16:11
03/04/21
03/04
16:11
03/04/21
16:11
HEAR

Turtle Beach

$28.41 /

-0.84 (-2.87%)

Sees Q1 revenue $88M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.41 /

-0.84 (-2.87%)

01/13/21
Turtle Beach acquires Neat Microphones, terms not disclosed
11/19/20
Turtle Beach and TIdal music platform expand partnership
10/16/20
Video game hardware spending rose 15% year-over-year in September, says NPD
HEAR Turtle Beach
$28.41 /

-0.84 (-2.87%)

02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
02/11/21 Lake Street
Turtle Beach price target raised to $40 from $30 at Lake Street
HEAR Turtle Beach
$28.41 /

-0.84 (-2.87%)

16:10 Today
Turtle Beach sees FY21 adjusted EPS $1.35, consensus $1.41
16:08 Today
Turtle Beach reports Q4 adjusted EPS 984c, consensus 78c
02/10/21
Turtle Beach sees Q4 adjusted EPS 73c-82c, consensus 47c
11/05/20
Turtle Beach raises FY20 adj. EPS view to $1.75 from 80c, consensus 96c
HEAR Turtle Beach
$28.41 /

-0.84 (-2.87%)

09/29/20
Fly Intel: After-Hours Movers
03/15/21
33rd Annual Roth Virtual Conference
17:00 Today
Turtle Beach - HEAR
Hot Stocks
Medallia to acquire Decibel for $160M in cash » 16:10
03/04/21
03/04
16:10
03/04/21
16:10
MDLA

Medallia

$37.54 /

-2.29 (-5.75%)

Medallia announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDLA Medallia
$37.54 /

-2.29 (-5.75%)

03/01/21
Medallia announces partnership with USA Rugby
01/21/21
U.S. HHS selects Medallia to improve key services
01/19/21
Medallia Speech gets FedRAM authorization, HIPAA compliance
01/07/21
Medallia's video feedback solution LivingLens achieves HIPAA compliance
MDLA Medallia
$37.54 /

-2.29 (-5.75%)

06:38 Today Citi
Citi adds Medallia to 'Value Creators' list, removes Dropbox
02/23/21 Citi
Medallia upgraded to Buy from Neutral at Citi
01/19/21 BTIG
Medallia price target raised to $49 from $37 at BTIG
01/19/21 BofA
Medallia initiated with a Buy at BofA
MDLA Medallia
$37.54 /

-2.29 (-5.75%)

16:09 Today
Medallia sees FY22 revenue $563M-$567M, consensus $554.79M
16:08 Today
Medallia sees Q1 revenue $126M-$128M, consensus $128.52M.
16:07 Today
Medallia reports Q4 EPS (1c), consensus (1c)
12/03/20
Medallia sees Q4 revenue $123.5M-$125.5M, consensus $122.83M
MDLA Medallia
$37.54 /

-2.29 (-5.75%)

12/03/20
Fly Intel: After-Hours Movers
03/10/21
2nd Annual Enterprise Comms Virtual Summit
03/15/21
33rd Annual Roth Virtual Conference
16:30 Today
Medallia - MDLA
Earnings
Durect reports Q4 cont ops EPS (4c), consensus (3c) » 16:10
03/04/21
03/04
16:10
03/04/21
16:10
DRRX

Durect

$2.04 /

-0.145 (-6.65%)

Reports Q4 revenue $2.2M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DRRX Durect
$2.04 /

-0.145 (-6.65%)

16:10 Today
Durect discontinues Covid trial due to lack of patients, other treatments
02/02/21
Durect announces FDA approval of POSIMIR
02/02/21
Durect jumps over 40% after FDA posts approval of pain drug
02/02/21
FDA posts approval of Durect pain treatment Posimir
DRRX Durect
$2.04 /

-0.145 (-6.65%)

02/03/21 Jefferies
Posimir should not be significant threat to Pacira's Exparel, says Jefferies
02/03/21 Chardan
Chardan boosts Durect target to $8 with 'final overhang' removed
02/02/21 Oppenheimer
Posimir approval a 'significant positive' for Durect, says Oppenheimer
02/02/21 Roth Capital
Roth reiterates $7 target on Durect after 'surprise' FDA approval
DRRX Durect
$2.04 /

-0.145 (-6.65%)

11/02/20
Durect reports Q3 EPS (5c), consensus (4c)
  • 04
    Feb
DRRX Durect
$2.04 /

-0.145 (-6.65%)

11/03/20
Fly Intel: Pre-market Movers
11/02/20
Fly Intel: After-Hours Movers
03/16/21
31st Annual Healthcare Virtual Conference
16:30 Today
Durect - DRRX
Earnings
Grid Dynamics reports Q4 adjusted EPS 4c, consensus 3c » 16:10
03/04/21
03/04
16:10
03/04/21
16:10
GDYN

Grid Dynamics

$14.81 /

-0.85 (-5.43%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/14/20
Grid Dynamics acquires Daxx, terms undisclosed
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/16/20 Canaccord
Grid Dynamics price target raised to $15 from $11 at Canaccord
10/15/20 Cowen
Grid Dynamics initiated with an Outperform at Cowen
09/28/20 Canaccord
Grid Dynamics initiated with a Buy at Canaccord
06/25/20 Loop Capital
Grid Dynamics price target raised to $84 from $77 at Loop Capital
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

12/21/20
Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades
GDYN Grid Dynamics
$14.81 /

-0.85 (-5.43%)

11/30/20
Two new option listings and one option delisting on November 30th
Earnings
Great Ajax Corp. reports Q4 EPS 47c, consensus 23c » 16:10
03/04/21
03/04
16:10
03/04/21
16:10
AJX

Great Ajax

$11.44 /

-0.27 (-2.31%)

Reports book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AJX Great Ajax
$11.44 /

-0.27 (-2.31%)

11/23/20 BTIG
Great Ajax initiated with a Neutral at BTIG
04/09/20 Piper Sandler
Mortgage Finance volatility brings 'unique opportunity,' says Piper Sandler
04/06/20 Raymond James
Raymond James cuts estimates and targets for residential mortgage REITs
17:00 Today
Great Ajax - AJX
AJX Great Ajax
$11.44 /

-0.27 (-2.31%)

10/14/20
Seven new option listings and three option delistings on October 14th

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.